RxDoctor Payments Data

Joseph Salamy

Physician Assistant · Massena, NYNPI 1447775036

Payments from drug & device makers

$3,187in general payments, 2019–2025

Across 158 payments — averaging $20.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$834
  • GSK$443
  • AbbVie$364
  • Novo Nordisk$362
  • Merck$272
  • Lilly USA, LLC$199
  • plus $714 from 16 others

What the payments were for

  • Food & beverage$3,12198%
  • Education$662%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,187 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide101$117,611
TrulicityDulaglutide56$70,546
EliquisApixaban59$68,236
FarxigaDapagliflozin Propanediol60$58,082
Breztri AerosphereBudesonide/Glycopyr/Formoterol79$54,683
Trelegy ElliptaFluticasone/Umeclidin/Vilanter57$45,927
RybelsusSemaglutide39$38,245
JardianceEmpagliflozin29$35,371
XareltoRivaroxaban28$34,953
DescovyEmtricitabine/Tenofov Alafenam11$27,460
EntrestoSacubitril/Valsartan13$14,810
MounjaroTirzepatide13$12,550
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$9,958
LinzessLinaclotide13$8,252
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$7,964

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$362$155,857140 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$834$119,142151 claims
Lilly USA, LLCTrulicity, Mounjaro$199$83,09769 claims
PfizerEliquis, Paxlovid$21$70,95772 claims
GSKTrelegy Ellipta, Anoro Ellipta$443$55,88574 claims
Boehringer IngelheimJardiance$28$35,37129 claims
Johnson & JohnsonXarelto$122$34,95328 claims
NovartisEntresto$49$14,81013 claims
AbbVieLinzess, Synthroid$364$9,45829 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Massena

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →